Abstract
The interleukins (ILs) comprise a group of small proteins or polypeptides with molecular weights in the 15–25 kD range. These polypeptides possess pleiotropic biological activities on immune as well as non-immune cells and can be produced by either cell type. At the present time, recombinant forms for at least IL-lα and β through IL-7 are available for investigative use, and these ILs possess certain overlapping biological activities. The use of the term interleukin is somewhat archaic and limiting since a variety of non-leukocytic cell types produce these molecules or others with similar biological activities. Designations for the ILs, based on cell type of origin, include monokines, lymphokines, and cytokines if they are derived from monocytes, lymphocytes, and non-lymphoid cells, respectively. Finally, there is a trend to refer to all of the above mentioned molecules as cytokines, and an appreciation of the multitude of biological effects induced by the cytokines can be found in several recent reviews (1,2,3,4).
Keywords
- Newcastle Disease Virus
- Chromaffin Cell
- Pituitary Cell
- Vasoactive Intestinal Polypeptide
- POMC mRNA Level
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bendtzen, K., Interleukin 1, interleukin 6 and tumor neurosis factor in infaction, inflammation and immunity,Immun Lett19: 183–191, 1988.
Dinarello, C.A., Interleukin-1 and its biologically related cytokines, In F.J. Dixon, (ed)Advances in ImmunologyAcademis Press, San Diego, Volume 44: 153–205, 1989.
Sipe, J.D., The molecular biology of interleukin-1 and the acute phase response, In G.H. Stollerman, W.J. Harrington, J.T. LaMont, J.J. Leonard, and M.D. Siperstein (eds)Advances in Internal Medicine,Year Book Medical Publishers, Inc. Chicago, Volume 34: 1–20, 1989.
Strober, W., and S.P. James, The interleukins,Pediatr Res24: 549–557, 1988.
Blalock, J.E., A molecular basis for bidirectional communication between the immune and neuroendocrine systems,Physiol Rev69: 1–32, 1989.
Eskay, R.L., A. Thigarajan, and L. Eiden, Interleukin-1 enhances the accumulation of epinephrine and vasoactive-intestinal polypeptide in cultured adrenal chromaffin cells,Program of the I9th Annual Meeting of the Society for Neuroscience,Phoenix, AZ, Abstract 156.2, p. 380, 1989.
Besedovsky, H., E. Sorkin, D. Felix, and H. Haas, Hypothalamic changes during the immune response,Eur J Immunol7: 323–325, 1977.
Besedovsky, H., E. Sorkin, M. Keller, and J. Müller, Changes in blood hormone levels during the immune response,Proc Soc Exp Biol Med150: 466–470, 1975.
Besedovsky, H.O., A. del Rey, and E. Sorkin, Lymphokine-containing supernatants from Con A-stimulated cells increase corticosterone blood levels, JImmunol126: 385–387, 1981.
Besedovsky, H.O., A. del Rey, E. Sorkin, and CA. Dinarello, Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones,Science233: 652–654, 1986.
Besedovsky, H.O., A. del Rey, and E. Sorkin, Immun-neuroendocrine interactions, JImmunol135: 750s–754s, 1985.
Sapolsky, R., C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale, Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor,Science238: 522–524, 1987.
Berkenbosch, F., J. van Oers, A. del Rey, F. Tilders, and H. Besedovsky, Cortocotropin-releasing factor-producing neurons in the rat activated by interleukin-1,Science238: 524–526, 1987.
Uehara, A., P.E. Gottschall, R.R. Dahl, and A. Arimura, Interleukin 1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor,Endocrinology121: 1580–1582, 1987.
Katsuura, G., P.E. Gottschall, R.R. Dahl, and A. Arimura, Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin,Endocrinology122: 1773–1779,1988.
Uehara, A., P.E. Gottschall, R.R. Dahl, and A. Arimura, Stimulation of ACTH release by human interleukin-1β, but not by interleukin-l, in conscious, freely-moving rats,Biochem Biophys Res Commun146: 1286–1290, 1987.
Tsagarakis, S., G. Gillies, L.H. Rees, M. Besser, and A. Grossman, Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus,Neuroendocrinology49: 98–101, 1989.
Ovadia, H., O. Abramsky, V. Barak, N. Conforti, D. Saphier, and J. Weidenfeld, Effect of interleukin-1 on adrenocortical activity in intact and hypothalamic deafferentated male rats,Exp Brain Res76: 246–249, 1989.
Besedovsky, H., A. del Rey, E. Sorkin, M. da Prada, R. Burri, and C. Honegger, The immune response evokes changes in brain noradrenergic neurons,Science221: 564–566, 1983.
Dunn, A J., M.L. Powell, W.V. Moreshead, J.M. Gaskin, and N.R. Hall, Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation,Brain Behav and Immunity1: 216–230, 1987.
Dunn, A.J., Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone,Life Sci43: 429–435, 1988.
Kabiersch, A., A. del Rey, C.G. Honegger, and H.O. Besedovsky, Interleukin-1 induces changes in norepinephrine metabolism in the rat brain,Brain Behav and Immunity2: 267–274,1988.
Plotsky, P.M., Facilitation of immunoreactive corticotropin-releasing factor secretion into hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection,Endocrinology121: 924–930, 1987.
Swanson, L.W., P.E. Sawchenko, and R.W. Lind, Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response, In T. Hökfelt, K. Fuxe, and B. Pernow (eds)Progress in Brain Research,Elsevier Science Publishers, New York, Volume 68: 169–190, 1986.
Szafarczyk, A., F. Malaval, A. Laurent, R. Gibaud, and I. Assenmacher, Further evidence for a central stimualtory action of catecholamines on adrenocorticotropin release in the rat,Endocrinology121:883–892, 1987.
Farrar, W.L., J.M. Hill, A. Harel-Bellan, and M. Vinocour, The immune logical brain,Immunol Rev100: 361–378, 1987.
Katsuura, G., P.E. Gottschall, and A. Arimura, Identification of a high-affinity receptor for interleukin-1 beta in the rat brain,Biochem Biophys Res Commun156: 61–67, 1988.
Breder, C.D., C.A. Dinarella, and C.B. Saper, Interleukin-1 immunoreactive innervation of the human hypothalamus,Science240: 321–324, 1988.
Nishida, T., N. Nishino, M. Takano, Y. Sekiguchi, K. Kawai, K. Mizuno, S. Nakai, Y. Masui, and Y. Hirai, Molecular cloning and expression of rat interleukin-1 alpha cDNA, JBiochem105: 351–357, 1989.
Nakamura, H., S. Motoyoshi, and T. Kadokawa, Anti-inflammatory action of interleukin 1 through the pituitary-adrenal axis in rats,Eur J Pharmacol151: 67–73, 1988.
Sharp, B.M., S.G. Matta, P.K. Peterson, R. Newton, C. Chao, and K. McAllen, Tumor necrosis factor is a potent ACTH secretogogue: comparison to interleukin-1,Endocrinology124: 3131–3133, 1989.
Kehrer, P., D. Turnill, J.M. Dayer, A.F. Muller, and R.C. Gaillard, Human recombinant interleukin-1 beta and -alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cellsin vitroin a prostaglandin E2 and cAMP independent manner,Neuroendocrinology48: 160–166, 1988.
Naitoh, Y., J. Fukata, T. Tominaga, Y. Nakai, S. Tamai, K. Mori, and H. Imura, Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats,Biochem Biophys Res Commun155: 1459–1463, 1988.
Bindon, C., M. Czerniecki, P. Ruell, A. Edwards, W. McCarthy, R. Harris, and P. Hersey, Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects,Br J Cancer47: 123–133, 1983.
Lotze, M.T., L.W. Frana, S.O. Sharrow, R.J. Robb, and S.A. Rosenberg,In vivoadministration of purified human interleukin 2. I. Half-like and immunologic effects of the Jurkat cell line-derived interleukin 2, JImmunol134: 157–166, 1985.
Lotze, M.T., Y.L. Matory, S.E. Ettinghausen, A.A. Rayner, S.O. Sharrow, C.A. Scipp; M.C. Custer, and S A. Rosenberg,In vivoadministration of purified human interleukin-2. II. Half-life, immunologic effects and expansion of peripheral lymphoid cellsin vivowith recombinant IL-2, JImmunol135: 2865–2875, 1985.
Michie, H.R., K.R. Manogue, D.R. Spriggs, A. Revhaug, S. O’Dwyer, CA. Dinarello, A. Cerami, S.M. Wolff, and D.W. Wilmore, Detection of circulating tumor necrosis factor after endotoxin administration,N Engl J Med318: 1481–1486, 1988.
Smith, L.R., S.L. Brown, and J.E. Blalock, Interleukin-2 induction of ACTH secretion: pressure of an interleukin-2 receptor chain-like molecule on pituitary cells, JNeuroimmunol21: 249–254, 1989.
Brown, S.L., L.R. Smith, and J.E. Blalock, Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells, JImmunol139: 3181–3183, 1987.
Farrar, W.L., Endorphin modulation of lymphokine activity, In F. Fraioli, A. Isidori, and M. Mazzetti (eds)Opioid Peptides in the Periphery, Elsevier, Amsterdam, pp. 159–165, 1984.
Bernton, E.W., J.E. Beach, J.W. Holaday, R.C. Smallridge, and H.G. Fein, Release of multiple hormones by direct action of interleukin-1 on pituitary cells,Science238: 519–521, 1987.
Beach, J.E., R.C. Smallridge, C.A. Kinzer, E.W. Bernton, J.W. Holaday, and H.G. Fein, Rapid release of multiple hormones from rat pituitaries perfused with recombinant interleukin-1,Life Sci44:1–7,1989.
Boyle, M., G. Yamamoto, M. Chen, J. Rivier, and W. Vale, Interleukin 1 prevents loss of corticotropic responsiveness to β-adrenergic stimulationin vitro, Proc Natl Acad Sci USA85: 5556–5560, 1988.
Suda, T., F. Tozawa, T. Ushiyama, N. Tomori, T. Sumitomo, Y. Nakagami, M. Yamada, H. Demura, and K. Shizume, Effects of protein kinase-C-related adrenocorticotropin secretagogues and interleukin-1 on proopiomelanocortin gene expression in rat anterior pituitary cells,Endocrinology124: 1444–1449,1989.
Uehara, A., S. Gillis, and A. Arimura, Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture,Neuroendocrinology45: 343–347, 1987.
Fagarasan, M.O., R. Eskay, and J. Axelrod, Interleukin 1 potentiates the secretion of β-endorphin induced by secretagogues in a mouse pituitary cell line (AtT-20),Proc Natl Acad Sci USA86: 2070–2073, 1989.
Woloski, B.M., E.M. Smith, W.J. Meyer, G.M. Fuller, and J.E. Blalock, Corticotropin-releasing activity of monokines,Science230: 1035–1037, 1985.
Axelrod, J., and T. Reisine, Stress hormones: their interaction and regulation,Science224: 452–459,1984.
Young, S., P.J. Parker, A. Ullrich, and S. Stabel, Down-regulation of protein kinase-C is due to an increased rat of degradation,Biochem J244: 775–779, 1987,
Mitchell, P.J., and R. Tjian, Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins,Science245: 371–378, 1989.
Malarkey, W.B., and B.J. Zvara, Interleukin-1ßand other cytokines stimulate adrenocorticotropin release from cultured pituitary cells of patients with Cushing’s disease, JClin Endocrinol Metab69:196–199,1989.
Roh, M.S., M.O. Kathleen A. Drazenovich, J.J. Barbose, C.A. Dinarello, and C.F. Cobb, Direct stimulation of the adrenal cortex by interleukin-1,Surgery102: 140–146, 1987.
Whitcomb, R.W., W.M. Linehan, L.M. Wahl, and R.A. Knazek, Monocytes stimulate Cortisol production by cultured human adrenocortical cells, JClin Endocrinol Metab66: 33–38, 1988.
Eiden, L.E., R.L. Eskay, J. Scott, H. Pollard, and A.J. Hotchkiss, Primary cultures of bovine chromaffin cells synthesize and secrete vasoactive intestinal polypeptide (VIP),Life Sci33: 687–693, 1983.
Pruss, R.M., J.R. Moskal, L.E. Eiden, and M.C. Beinfeld, Specific regulation of vasoactive intestinal polypeptide biosynthesis by phorbal ester in bovine chromaffin cells,Endocrinology117:1020–1026,1985.
Fong, Y., L. Moldawer, M. Marano, H. Wei, S.B. Tatter, R.H. Clarick, U. Santhanam, D. Sherris, L.T. May, P.B. Sehgal, and S.F. Lowry, Endotoxemia elicits increased circulating β2-IFN/IL-6 in man, JImmunol142: 2321–2324, 1989.
Zuckerman, S.H., J. Shellhaas, and L.D. Butler, Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis,Eur J Immunol19: 301–305, 1989.
Stern,L., and G. Kunos, Synergistic regulation of pulmonary β-adrenergic receptors by glucocorticoids and interleukin-1,J Biol Chem263: 15876–15879,1988.
Vale, W., J. Vaughan, M. Smith, G. Yamamoto, J. Rivier, and C. Rivier, Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophyseal peptides and other substances on cultured corticotropin cells,Endocrinology113: 1121–1131, 1983.
Dave, J.R. N. Rubenstein, and R.L. Eskay, Evidence that β-endorphin binds to specific receptors in rat peripheral tissues and stimulates the adenylate cyclase-adenosine 3′,5′-monophosphate system,Endocrinology117: 1389–1396, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Eskay, R.L., Grino, M., Chen, H.T. (1990). Interleukins, Signal Transduction, and the Immune System-Mediated Stress Response. In: Porter, J.C., Ježová, D. (eds) Circulating Regulatory Factors and Neuroendocrine Function. Advances in Experimental Medicine and Biology, vol 274. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5799-5_21
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5799-5_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5801-5
Online ISBN: 978-1-4684-5799-5
eBook Packages: Springer Book Archive